Last updated on October 2018

EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)

Brief description of study

The aim of the study is to investigate the safety and efficacy of empagliflozin versus placebo on top of guideline-directed medical therapy in patients with heart failure with reduced ejection fraction.

Clinical Study Identifier: NCT03057977

Contact Investigators or Research Sites near you

Start Over

Pawel Miekus

Saint Wincenty a Paulo Hosp., Cardiology Dept., Gdynia
Gdynia, Poland
  Connect »

Krzysztof Cymerman

Indywidualna Specjalistyczna Praktyka Lekarska
Gdynia, Poland
  Connect »